Who owns AGMB?
Institutional ownership of AgomAb Therapeutics NV from Form 13F, Q2 2026
34 institutional managers reported holding AgomAb Therapeutics NV (AGMB) in Form 13F filings for Q2 2026, with 27,523,670 shares worth $357M. The largest reported holder was EQT Fund Management S.a r.l. Managers that filed both quarters added a net 4,169,443 shares (+17.9%). 9 opened new positions and 7 sold out.
- Funds holding
- 34
- Value held
- $357M
- New / sold out
- 9 / 7
- Net shares, same filers
- +17.9%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of AGMB
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| EQT Fund Management S.a r.l. | $66.7M | 18.7% | 5,141,992 | Unchanged |
| Nantahala Capital Management, LLC | $40.7M | 11.4% | 3,136,376 | Added |
| Sanofi | $36.1M | 10.1% | 2,783,096 | Unchanged |
| Redmile Group, LLC | $35.5M | 9.9% | 2,733,926 | Added |
| Cormorant Asset Management, LP | $32.0M | 9.0% | 2,465,348 | Unchanged |
| TCG Crossover Management, LLC | $26.7M | 7.5% | 2,053,233 | Unchanged |
| Federated Hermes, Inc. | $21.0M | 5.9% | 1,618,000 | Unchanged |
| Casdin Capital, LLC | $20.1M | 5.6% | 1,550,000 | Unchanged |
| Andera Partners | $20.0M | 5.6% | 1,538,702 | Unchanged |
| FMR LLC | $18.9M | 5.3% | 1,458,677 | Unchanged |
| Aberdeen Group plc | $11.0M | 3.1% | 846,695 | Added |
| Samsara Biocapital, LLC | $7.8M | 2.2% | 600,000 | Unchanged |
| Perceptive Advisors LLC | $7.8M | 2.2% | 600,000 | Unchanged |
| Siren, L.L.C. | $5.3M | 1.5% | 411,250 | Unchanged |
| Orbimed Advisors LLC | $2.5M | 0.7% | 192,740 | New |
| Pfizer Inc | $1.0M | 0.3% | 75,000 | Unchanged |
| Alps Advisors Inc | $649K | 0.2% | 49,984 | New |
| Bellevue Group AG | $639K | 0.2% | 49,248 | Trimmed |
| Seven Grand Managers, LLC | $618K | 0.2% | 47,600 | Trimmed |
| Sectoral Asset Management Inc | $565K | 0.2% | 43,500 | Unchanged |
| Burkehill Global Management, LP | $454K | 0.1% | 35,000 | Unchanged |
| Quadrature Capital Ltd | $266K | 0.1% | 20,461 | New |
| Two Sigma Investments, LP | $235K | 0.1% | 18,072 | Added |
| HRT Financial LP | $221K | 0.1% | 17,075 | Trimmed |
| Goldman Sachs Group Inc | $153K | 0.0% | 11,800 | Trimmed |
Share of 13F holdings is each fund's shares as a share of the 27,523,670 AGMB shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Redmile Group, LLC Added+$33.5M
- Nantahala Capital Management, LLC Added+$25.1M
- Orbimed Advisors LLC New+$2.5M
- Aberdeen Group plc Added+$1.8M
- Alps Advisors Inc New+$649K
- Quadrature Capital Ltd New+$266K
- XTX Topco Ltd New+$133K
- Citigroup Inc New+$123K
- Two Sigma Investments, LP Added+$50K
- GAMMA Investing LLC New+$17K
Biggest sellers in Q2 2026
- LMR Partners LLP Sold out-$3.1M
- Seven Grand Managers, LLC Trimmed-$2.0M
- Millennium Management LLC Sold out-$999K
- Alyeska Investment Group, L.P. Sold out-$787K
- Laurion Capital Management LP Sold out-$525K
- Citadel Advisors LLC Sold out-$367K
- Goldman Sachs Group Inc Trimmed-$311K
- D. E. Shaw & Co., Inc. Sold out-$161K
- Jane Street Group, LLC Sold out-$134K
- HRT Financial LP Trimmed-$86K
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $64.2M and sold $8.6M; 4 added and 6 trimmed.
Schedule 13D and 13G filings on AGMB
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-05-15Redmile Group, LLC SCHEDULE 13G filed by AgomAb Therapeutics NVSchedule 13G
- 2026-05-15Cormorant Asset Management, LP SCHEDULE 13G filed by AgomAb Therapeutics NVSchedule 13G
- 2026-05-06Sanofi SCHEDULE 13G filed by AgomAb Therapeutics NVSchedule 13G
- 2026-04-16Pontifax Management 4 G.P. (2015) Ltd. SCHEDULE 13G filed by AgomAb Therapeutics NVSchedule 13G
- 2026-03-06FMR LLC SCHEDULE 13G filed by AgomAb Therapeutics NVSchedule 13G
- 2026-02-17LSP 7 Cooperative UA SCHEDULE 13D filed by AgomAb Therapeutics NVSchedule 13D
Questions about AGMB ownership
- Who owns AGMB stock?
- 34 institutional investment managers reported AGMB positions in their Form 13F filings for Q2 2026, holding 27,523,670 shares worth $357M in total. EQT Fund Management S.a r.l. reported the largest position.
- Are funds buying or selling AGMB?
- In Q2 2026, 9 managers opened new AGMB positions, 4 added, 6 trimmed and 7 sold out. Managers that filed in both quarters added a net 4,169,443 shares.
- How current is this AGMB institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to AGMB by CUSIP. Options are left out. AGMB news and filings · AGMB insider trades · Top funds